Intellectual Disability
0
Pipeline Programs
4
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Providence TherapeuticsAB - Calgary
1 programAdapted Dialectical Behaviour TherapyN/A1 trial
Active Trials
GenomicsUK - Oxford
1 programGenomic sequencing and molecular diagnostic results, if any.N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
GenomicsGenomic sequencing and molecular diagnostic results, if any.
Novo NordiskPhysical activity
CENTOGENEBiomarker for Creatine Deficiency Syndromes (BioCDS)
Providence TherapeuticsAdapted Dialectical Behaviour Therapy
Clinical Trials (4)
Total enrollment: 235 patients across 4 trials
Mental Health Crises in Youth With IDDs
Start: Mar 2023Est. completion: Jul 2027150 patients
N/ARecruiting
Physical Activity, Sports and Health in Adults With Intellectual Disabilities
Start: Aug 2019Est. completion: Dec 202285 patients
N/AUnknown
Biomarker for Creatine Deficiency Syndromes (BioCDS)
Start: Aug 2018Est. completion: Feb 20210
N/AWithdrawn
Dialectical Behaviour Group Therapy for Adults With Intellectual Disabilities
Start: Aug 2016Est. completion: Mar 2018
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 235 patients
4 companies competing in this space